Premium
Second‐generation platelet concentrate (PRF) as a pulpotomy medicament in a permanent molar with pulpitis: a case report
Author(s) -
Hiremath H.,
Saikalyan S.,
Kulkarni S. S.,
Hiremath V.
Publication year - 2012
Publication title -
international endodontic journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.988
H-Index - 119
eISSN - 1365-2591
pISSN - 0143-2885
DOI - 10.1111/j.1365-2591.2011.01973.x
Subject(s) - pulpotomy , dentistry , mineral trioxide aggregate , medicine , molar , pulpitis , pulp capping , pulp (tooth) , permanent teeth , amalgam (chemistry) , endodontics , orthodontics , chemistry , electrode
Hiremath H, Saikalyan S, Kulkarni SS, Hiremath V. Second‐generation platelet concentrate (PRF) as a pulpotomy medicament in a permanent molar with pulpitis: A case report. International Endodontic Journal , 45 , 105–112, 2012. Abstract Aim To discuss the clinical and radiographic success of a pulpotomy with second‐generation platelet concentrate (PRF), in a human mature permanent molar tooth. Summary A 19‐year‐old female patient reported to the Department of Conservative Dentistry and Endodontics with established pulpitis in tooth 36. The tooth had a carious pulp exposure, with a history of lingering pain. After isolation, caries removal and pulp exposure, pulpotomy with PRF was performed and a permanent restoration was placed immediately. At the first recall (+1 day), no postoperative pain was reported. At 6, 12, 18 and 22 months recall, the tooth responded positively to pulp sensibility tests, and radiographic examination revealed a normal periodontal ligament space. Positive results of this case imply the need for more studies with larger sample sizes and a longer recall period to justify the use of this novel material for the treatment of pulpitis in human permanent molar teeth. Key learning points • Pulpotomy with PRF could be an alternate treatment to mineral trioxide aggregate or other materials in mature permanent teeth with pulpitis.